TuisAVH • ASX
add
AVITA Medical Inc
Vorige sluiting
$3,98
Dagwisseling
$3,86 - $3,96
Jaarwisseling
$2,34 - $5,62
Markkapitalisasie
529,79 m AUD
Gemiddelde volume
220,31 k
Finansieel
Inkomstestaat
Inkomste
Netto inkomste
| (USD) | Sep. 2024info | J/J-verandering |
|---|---|---|
Inkomste | 19,55 m | 43,25% |
Bedryfskoste | 30,16 m | 44,75% |
Netto inkomste | -16,20 m | -86,01% |
Netto winsgrens | -82,91 | -29,85% |
Wins per aandeel | -0,93 | -75,60% |
EBITDA | -13,50 m | -47,63% |
Effektiewe belastingkoers | 0,17% | — |
Balansstaat
Totale bates
Totale aanspreeklikheid
| (USD) | Sep. 2024info | J/J-verandering |
|---|---|---|
Kontant en korttermynbeleggings | 44,40 m | -26,14% |
Totale bates | 81,05 m | 0,05% |
Totale aanspreeklikheid | 68,82 m | 281,59% |
Totale ekwiteit | 12,23 m | — |
Uitstaande aandele | 26,22 m | — |
Prys om te bespreek | 8,47 | — |
Opbrengs op bates | -40,88% | — |
Opbrengs op kapitaal | -54,41% | — |
Kontantvloei
Netto kontantverandering
| (USD) | Sep. 2024info | J/J-verandering |
|---|---|---|
Netto inkomste | -16,20 m | -86,01% |
Kontant van bedrywe | -7,21 m | 19,61% |
Kontant van beleggings | 7,39 m | -66,02% |
Kontant van finansiering | 1,01 m | 67,83% |
Netto kontantverandering | 1,19 m | -91,12% |
Beskikbare kontantvloei | -5,35 m | 35,08% |
Meer oor
Avita Medical is a clinical and commercial company developing and marketing a range of respiratory and regenerative products. The first regenerative medicine product brought to the market by Avita Medical was ReCell spray-on skin for the treatment of burns. The two latest products are ReNovaCell, for Aesthetics and Plastic applications including skin trauma, and ReGenerCell for the treatment of chronic wounds. The Avita Medical regenerative product range is currently marketed in Europe, the Middle East, Africa and Australia. Wikipedia
Gestig
1999
Hoofkwartier
Webwerf
Werknemers
207
